A pharmacoepidemiological study of Rivaroxaban use and potential adverse outcomes in routine clinical pratice in the Netherlands

Study protocol

Initial protocol

16646_PHARMO_Rivaroxaban protocol

English (702.54 KB - PDF) View document

Study results

EUPAS11141-43170

English (152.16 KB - PDF) View document

Study report

16646_Progress Report_v1.0_2019-01-28

English (93.28 KB - PDF) View document

EUPAS11141-43221

English (592.92 KB - PDF) View document

Other information

Secondary tabs